Free Trial

Lifecore Biomedical Q1 2025 Earnings Report

Lifecore Biomedical logo
$5.91 -0.96 (-13.97%)
As of 01/7/2025 04:00 PM Eastern

Lifecore Biomedical EPS Results

Actual EPS
-$0.53
Consensus EPS
-$0.46
Beat/Miss
Missed by -$0.07
One Year Ago EPS
N/A

Lifecore Biomedical Revenue Results

Actual Revenue
$24.71 million
Expected Revenue
$23.30 million
Beat/Miss
Beat by +$1.41 million
YoY Revenue Growth
N/A

Lifecore Biomedical Announcement Details

Quarter
Q1 2025
Time
N/A

Conference Call Resources

Collect $7k per month from Tesla’s SECRET dividend (Ad)

Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…

Click here to discover the new #1 way to invest in Tesla

Lifecore Biomedical Earnings Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
See More Lifecore Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Lifecore Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your email.

About Lifecore Biomedical

Lifecore Biomedical (NASDAQ:LFCR), together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

View Lifecore Biomedical Profile

More Earnings Resources from MarketBeat